Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
Small extracellular vesicles administered directly in the brain promote neuroprotection and decreased microglia
Miguel M Lino1, Tiago Rondão1, Arnab Banerjee1
1CNC - Centre for Neuroscience and Cell Biology, CIBB - Centre for Innovative Biomedicine and Biotechnology, Coimbra, Portugal. lino.ferreira@uc.pt.
Abstract:
Herein, we investigate the bioactivity of small extracellular vesicles (sEVs), focusing on their local effect in the brain. sEVs from mononuclear cells (MNCs) showed superior effects in vitro to sEVs from mesenchymal stem cells (MSCs) and were able to promote neuroprotection and decrease microglia reactivity in a stroke mouse model.
Insights
Small extracellular vesicles (sEVs) from mononuclear cells (MNCs) demonstrated superior neuroprotective effects compared to those from mesenchymal stem cells (MSCs). These MNC-derived sEVs reduced brain inflammation in a stroke model.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Small extracellular vesicles (sEVs) are crucial mediators of intercellular communication.
- Their therapeutic potential in neurological disorders is under investigation.
- Understanding the source and function of sEVs is key to harnessing their benefits.
Purpose of the Study:
- To compare the bioactivity of sEVs derived from different cell sources.
- To evaluate the local effects of sEVs within the brain.
- To assess the neuroprotective capacity of sEVs in a stroke model.
Main Methods:
- Isolation and characterization of sEVs from mononuclear cells (MNCs) and mesenchymal stem cells (MSCs).
- In vitro assessment of sEV bioactivity.
- Administration of sEVs in a mouse model of stroke.
- Evaluation of neuroprotection and microglia reactivity.
Main Results:
- sEVs from MNCs exhibited significantly greater bioactivity in vitro compared to sEVs from MSCs.
- MNC-derived sEVs demonstrated neuroprotective effects in the stroke mouse model.
- Treatment with MNC-derived sEVs led to a decrease in microglia reactivity.
Conclusions:
- Mononuclear cell-derived sEVs hold superior therapeutic potential for brain conditions over MSC-derived sEVs.
- sEVs can exert local neuroprotective effects and modulate neuroinflammation.
- Further research into MNC-derived sEVs is warranted for stroke treatment strategies.
More Related Videos
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024
10:21Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018